MAPS Act

The MAPS Act (Mapping America's Pharmaceutical Supply Act) would direct the Secretary of Health and Human Services to work with other federal agencies to improve oversight of essential medicine supply chains. The bill would require maintaining a list of critical medicines important for national security, public health emergencies, and military preparedness, with updates at least every two years. The list would include medicines needed for chemical, biological, radiological, or nuclear threats; medicines at risk of shortage; and medicines critical for military readiness.

The bill would also require a comprehensive risk assessment of these essential medicine supply chains, identifying key manufacturing materials, foreign dependencies, domestic manufacturing capabilities, and potential national security vulnerabilities. Additionally, the bill would mandate creation of a supply chain mapping system using data analytics to visualize the entire production process from raw materials to finished drugs. This system would facilitate information sharing between federal agencies and help identify vulnerabilities in the pharmaceutical supply chain. Reports on these efforts would be submitted to Congress regularly to track progress and coordinate activities across agencies.